Skip to main content
SYK
NYSE Life Sciences

赛特克收购血管振幅系统公司,凭借下一代IVL技术提升外周血管产品组合

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$338.1
Mkt Cap
$129.789B
52W Low
$319.32
52W High
$404.87
Market data snapshot near publication time

summarizeSummary

赛特克已签署最终协议,收购私营医疗技术公司血管振幅系统公司(AVS),该公司专门从事下一代血管内石灰化碎石(IVL)技术,用于治疗钙化外周动脉疾病。该战略性收购预计将显著加强赛特克外周血管产品组合的实力,通过在快速增长的市场细分中添加先进的再血管化技术。该举动符合赛特克扩大动脉疾病治疗存在感并解决未满足的临床需求的既定战略,从而可能推动未来的收入增长。交易双方将关注交易的完成以及随后关于财务条款或对赛特克收益预期影响的任何后续披露,以及AVS产品的监管审批。

在该公告发布时,SYK的交易价格为$338.10,交易所为NYSE,所属行业为Life Sciences,市值约为$1297.9亿。 52周交易区间为$319.32至$404.87。 这则新闻被评估为积极市场情绪,重要性评分为7/10。 来源:GlobeNewswire。


show_chartPrice Chart

Share this article

Copied!

feed SYK - Latest Insights

SYK
Apr 14, 2026, 12:59 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
SYK
Apr 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
SYK
Apr 09, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
7
SYK
Mar 23, 2026, 1:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
SYK
Mar 23, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
SYK
Mar 23, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
SYK
Mar 12, 2026, 5:27 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
SYK
Mar 12, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
8
SYK
Mar 11, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
8
SYK
Mar 11, 2026, 3:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
8